Legal Representation
Attorney
Thad Chaloemtiarana
USPTO Deadlines
Next Deadline
1991 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250708)
Due Date
July 08, 2031
Grace Period Ends
January 08, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
35 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 8, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 8, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jul 16, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jun 18, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jun 18, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 18, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 16, 2025 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 9, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 9, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 9, 2025 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 9, 2025 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| May 29, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Mar 4, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| May 29, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 5, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Mar 3, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 13, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 13, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 13, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 19, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 19, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Jun 19, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jun 19, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 12, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 10, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jan 10, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jan 10, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 1, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 6, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 6, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 17, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 3, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 28, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 4, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 18, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, cell therapy to treat diseases associated with inflammation such as autoimmune and
neurodegenerative diseases, and biologic medications that reduce effector cells involved in diseases associated with
inflammation, particularly, autoimmune and neurodegenerative diseases
First Use Anywhere:
Aug 12, 2024
First Use in Commerce:
Aug 12, 2024
Classification
International Classes
005